ANGION BIOMEDICA

#3692 COMPANY RANKING
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3777, a hepatocyte growth factor mimetic for acute kidney injury, acute lung injury, acute respiratory distress syndrome, central nervous system injuries, and heart injuries. It also develops ANG-3070, a tyrosine kinase inhibitor and rho kinase 2 inhibitors for fibrotic diseases; and CYP11B2, an aldosterone synthase inhibitor for aldosterone-related fibrotic diseases. The company was incorporated in 1998 and is based in Uniondale, New York.
computer emoji
angion.com
light emoji
Since 1998
#biotechnology#software-development#business-development
Company IndexTech Stories & NewsABOUTRelated Companies
Claim This Company
#3692
Ranking Index(All Ranking)
0%
Grow & Performance(seo & stats)
0
Traffic(Website traffic, unique visiotrs & user retention)

ANGION BIOMEDICA (ANGN)

5D1M6Mmax

EVERGREEN INDEX #3692

Angion Biomedica's stories on HackerNoon

Technology evolves every day, impacting our lives more and more. Don’t miss out on the tech of tomorrow via these remarkable technology stories.
Meet the Winners of Startups in North and Central America

Meet the Winners of Startups in North and Central America

Mon Feb 28 2022 By Startups of The Year

Angion Biomedica's latest news & mentions

Explore a rich selection of stories about your favorite games, how they are made, and the people that make them, from gamers and game developers worldwide.
Ischemia Reperfusion Injury Treatment Market: Paving the Way to a $1.58 Billion Valuation by 2033 through Harmonious Healing-FMI Projection

Ischemia Reperfusion Injury Treatment Market: Paving the Way to a $1.58 Billion Valuation by 2033 through Harmonious Healing-FMI Projection

fmiblog.com

Wed Nov 01 2023

Oxford BioMedica PLC (OXB)

Oxford BioMedica PLC (OXB)

investing.com

Wed Oct 18 2023

Chutes & Ladders—CEPI's founding CEO set to lead public health charity Wellcome

Chutes & Ladders—CEPI's founding CEO set to lead public health charity Wellcome

fiercebiotech.com

Fri Oct 13 2023

Director dealings: TUI, Oxford Biomedica board members linked to buys

Director dealings: TUI, Oxford Biomedica board members linked to buys

sharecast.com

Fri Oct 13 2023

Elicio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer’s (SITC 2023) Annual Meeting

Elicio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer’s (SITC 2023) Annual Meeting

markets.businessinsider.com

Wed Oct 11 2023

Is Angion Biomedica Corp (ELTX) Stock a Good Investment?

Is Angion Biomedica Corp (ELTX) Stock a Good Investment?

aaii.com

Fri Oct 06 2023

Ischemia Reperfusion Injury Therapeutics Market Market Share |Scope|Forecast

Ischemia Reperfusion Injury Therapeutics Market Market Share |Scope|Forecast

linkedin.com

Tue Oct 03 2023

Liver Diseases Treatment Market | Abbott Laboratories, Achillion Pharmaceuticals, Angion Biomedica, BPL Medical Technologies

Liver Diseases Treatment Market | Abbott Laboratories, Achillion Pharmaceuticals, Angion Biomedica, BPL Medical Technologies

benzinga.com

Mon Oct 02 2023

Mechanisms of Disease: Mechanisms of Hepatic Fibrosis and Therapeutic Implications

Mechanisms of Disease: Mechanisms of Hepatic Fibrosis and Therapeutic Implications

medscape.com

Mon Oct 02 2023

Leading Companies like Roche and Novartis at the Helm of the Global Rapidly Expanding IPF Treatment Market to 2030

Leading Companies like Roche and Novartis at the Helm of the Global Rapidly Expanding IPF Treatment Market to 2030

finance.yahoo.com

Tue Sep 26 2023

Ischemia Reperfusion Injury Treatment Market: Harmonizing Healing on a Path to US$ 1580 Million by 2033

Ischemia Reperfusion Injury Treatment Market: Harmonizing Healing on a Path to US$ 1580 Million by 2033

pharmiweb.com

Tue Sep 26 2023

Analysts Just Slashed Their Oxford Biomedica plc (LON:OXB) EPS Numbers

Analysts Just Slashed Their Oxford Biomedica plc (LON:OXB) EPS Numbers

finance.yahoo.com

Mon Sep 25 2023

Angion Biomedica's Related Companies

Explore a rich selection of stories about your favorite games, how they are made, and the people that make them, from gamers and game developers worldwide.
Colossal Biosciences-logo

Colossal Biosciences

colossal.com

#5667 RANK
light emojiFounded
2021
money emojiWorth
10B

ACS biotech-logo

ACS biotech

acsbiotech.com

#12106 RANK
light emojiFounded
2013

Amplified Sciences -logo

Amplified Sciences

amplifiedsciences.com

#7109 RANK
light emojiFounded
2016

biologit-logo

biologit

biologit.com

#12087 RANK
light emojiFounded
2019

Ellogon AI-logo

Ellogon AI

ellogon.ai

#8071 RANK
light emojiFounded
2019
Foray bioscience-logo

Foray bioscience

foraybio.com

#7576 RANK

Representing this company? Click here to claim and customize this page!

Reviews About Angion Biomedica

avatar

Angion Biomedica WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!